Search for: "Gilead Sciences Limited"
Results 21 - 40
of 84
Sort by Relevance
|
Sort by Date
23 Jun 2020, 11:30 am
Just this spring, Gilead Sciences, Inc., of Foster City, Ca., bought a firm backed directly and indirectly by CIRM with $45 million. [read post]
12 May 2020, 7:49 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceThe antiviral drug remdesivir, developed by California-based biopharmaceutical company Gilead Sciences in collaboration with government scientists, has emerged as the new standard of care for COVID-19 patients. [read post]
21 Apr 2020, 2:01 am
In Gilead Sciences, Inc. v. [read post]
18 Apr 2020, 4:03 am
Brainard is the head of antiviral clinical research at Gilead Sciences, the Bay Area biotech giant whose drug portfolio includes the antiviral medicine remdesivir. [read post]
12 Apr 2020, 6:03 am
As the Financial Times reported, Gilead Sciences renounced an orphan drug designation in the US that granted special status to its potential coronavirus treatment remdesivir. [read post]
24 Mar 2020, 12:07 pm
So what exactly is going on, and does it mean that Gilead Sciences, the biotechnology company that makes the drug (called remdesivir) is going to jack up its prices so that only the rich survive? [read post]
10 Mar 2020, 6:48 am
., a grantee of the stem cell agency, by Gilead Sciences, Inc., for $4.9 billion. [read post]
9 Mar 2020, 1:21 pm
Explanation of how contracts can limit doctors from using the drug of choice for patients: specialty pharmacy delivers drug to practice despite what they have chosen for inventory. [read post]
5 Sep 2019, 2:30 am
Both the story and Grassley’s letter refer to the DOJ’s attempt to dismiss a case against drugmaker Gilead Sciences. [read post]
3 Mar 2019, 9:15 am
"Based on feedback from partners and our work in the field, we believe that one of the greatest barriers to Truvada for PrEP access today is limited awareness of Truvada for PrEP’s role in HIV prevention," Gilead told IPWatchdog. [read post]
3 Feb 2019, 7:44 am
" This basic science is crucial, and expensive. [read post]
17 Jan 2019, 6:50 am
Anders ValentinGilead Sciences vs Sandoz – Round One The history of the case started in 2018, where Gilead Sciences Inc., brought preliminary injunctions before the court against several companies. [read post]
21 Dec 2018, 2:15 am
Applying the Federal Circuit case Gilead Sciences, Inc. v. [read post]
20 Dec 2018, 10:14 am
In Gilead Sciences, Inc. v. [read post]
17 Nov 2018, 12:29 pm
Gilead Sciences.) [read post]
17 Nov 2018, 12:29 pm
Gilead Sciences.) [read post]
8 Nov 2018, 2:47 am
Speakers include Jocelyn Man (Gilead), Joanna Peak (Boult Wade Tennant), Rob Whittock (Hardwicke Chambers), Alexandra Pygall (Stephenson Harwood), and Mark Abthorpe (Kilburn & Strode). [read post]
11 Oct 2018, 12:57 am
Eszter SzakácsCo-author: Zsolt Lengyel, Danubia Patent and Law Office Just a few months before the CJEU’s judgment in C-121/17 Teva UK Ltd and Others v Gilead Sciences Inc. came out a the Metropolitan Court of Budapest handed down a decision regarding Merck Sharp and Dohme Corp’s (MSD) application for an SPC re the combination of ezetimibe and rosuvastatin. [read post]
26 Sep 2018, 6:00 pm
Gilead Sciences, Inc., Docket No. 18-378 (Supreme Court 2018) In its newly filed petition for writ of certiorari, Merck asks one simple question: Whether the equitable defense of unclean hands precludes legal relief in the form of damages. [read post]
17 Sep 2018, 9:30 am
Brown, Zaha Hassan, Gilead Sher and Joyce Karam. [read post]
